Ezaki Glico Co., Ltd.
Fiscal Year Ending December 2026 Third Quarter Financial Summary [Japanese GAAP] (Consolidated)
For the nine months ended September 30, 2026 (FY Dec 2026 Q3 cumulative), consolidated net sales were 281,008 million yen, up 6.1% year-over-year. Operating income was 8,246 million yen, down -8.6% year-over-year. Ordinary income was 11,056 million yen, up 1.7% year-over-year. Net income attributable to owners of parent was 7,719 million yen, up 6.2% year-over-year. Strong revenue growth in overseas operations contributed. Full-year forecasts remain unchanged from the previous announcement. Treasury stock increased to 36,536 million yen due to share buyback activity.
Key Figures
- Net Sales: 281,008 million yen (Up 6.1% year-over-year)
- Operating Income: 8,246 million yen (Down -8.6% year-over-year)
- Net Income Attributable to Owners of Parent: 7,719 million yen (Up 6.2% year-over-year)
AI要約
Overview of Results
Ezaki Glico Co., Ltd. reported consolidated net sales of 281,008 million yen for the nine months ended September 30, 2026 (January 1 to September 30), a 6.1% increase year-over-year. However, due to a rise in cost of goods sold and other factors, operating income decreased year-over-year. Nonetheless, increased sales and profit contributions from overseas operations led to an increase in ordinary income. Expansion in overseas markets, including growth in China, boosted overall profit contribution. Supplementary materials to the financial results include detailed segment information.
Outlook and Capital Policy
The full-year forecast remains as announced in August. The company has executed share buybacks, and treasury stock at period-end amounted to 36,536 million yen. As part of stabilizing capital structure and capital policy, attention will be paid to future shareholder returns and efforts to improve capital efficiency.
Revenue by Segment
Operating Profit by Segment
Guidance Comparison
Ezaki Glico Co., Ltd.
Company overview · Stock price · Financial data · All IR
